Beta: Sign in
Shares outstandingAs of 2026-07-30 · filed common shares: 18.67M
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 3.30%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 17.04%
Short ratioDays to cover, as published by FINRA: 9.11
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 64.80%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 65.10%
Avg volume (10D)

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Rev growth (fwd)

Avg volume (3 months)

Profitability

Gross marginTTM to Jun 26: 91.39%
Operating marginTTM to Jun 26: 31.45%
Net margin: —
EBITDA marginTTM to Jun 26: 32.41%
Return on equityNet income (TTM to Jun 26) ÷ average shareholders equity: 126.90%
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: 88.46%

Growth

Revenue growth (annual YoY): 64.15%
Revenue growth (latest qtr YoY): -22.60%
Revenue growth (fwd): Sign in
Net income growth (annual YoY)FY Dec 25 vs FY Dec 24: 1999.08%
Net income growth (latest qtr YoY): -71.00%
EPS growth (fwd): Sign in
Net income growth (QoQ): 99.79%

Valuation

Market cap: Sign in
Enterprise value: Sign in
P/E: Sign in
P/E (fwd): Sign in
PEG: Sign in
PEG (fwd): Sign in
Price / book: Sign in
Price / sales

Price / operating cash flow

P/FCF

EV / revenue

EV / EBITDA

EPSDiluted, TTM to Jun 26

16.89

EPS (fwd)

Financial health

Cash & equivalentsas of Jun 26: $60.81M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $714.00K
Debt / equityas of Jun 26: 0.17%
Current ratioas of Jun 26: 1.94
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Jun 26: 1.58
Operating cash flowTTM to Jun 26: $79.38M
Free cash flow (six months)Six months: 2026-01-01 to 2026-06-30 · Not annualized: $33.37M
TTM revenue / diluted shareDiluted, TTM to Jun 26: 14.14

RIGL stock Statistics — Rigel Pharmaceuticals INC filings, insiders & smart money · Instaport